Your Messages Inbox
Your Article Summary
See Latest ArticlesVery good second quarter 2009 Increase in 2009 guidance
Sanofi-aventis, 07/30/09
In order to facilitate an understanding of our operational performance, we comment on our adjusted income statement excluding selected items1, a non–GAAP financial measure. The 2009 first–half consolidated income statement is provided in Appendix 5, as are details of adjustments and selected items. Consolidated net income for the first half of 2009 was €2,637 million, versus €2,335 million for the first half of 2008. Consolidated earnings per share for the first half of 2009 was €2.02, against €1.78 for the first half of 2008.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
IMS Predicts 4% to 6% Global Pharma Market Growth Next Year
U.S. Pharmacist, 12/02/09
Article Search
Sponsor